Close

VIVO Financial Facts

BASIC EARNINGS PER COMMON SHARE: 0.13
EFFECT OF DILUTIVE STOCK OPTIONS: -756K
See Full Income Statement

Accounts payable: -14.86M
Subtotal: -153.56M
See Full Balance Sheet

Meridian Bioscience Inc. (VIVO) Earnings

  |   Expand Research on VIVO
Next EPS Date N/A EPS Growth Rate -100.0% *Last Qtr.
Average EPS % Beat Rate +39.6% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +5.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
1/26/23 Q123 N/A$0.20 N/A N/A$72.3M N/A N/A N/A
11/10/22 Q422 N/A$0.20 N/A N/A$71.95M = N/A N/A
11/14/22 Q422 N/A$0.12 N/A N/A$63M = N/A N/A
8/5/22 Q322 $0.16$0.17 -$0.01$67.8M$66.8M = Details
5/6/22 Q222 $0.67$0.32 +$0.35$111.2M$83.29M = Details
2/4/22 Q122 $0.35$0.25 +$0.10$88.3M$70.29M = Details
11/12/21 Q421 $0.23$0.20 +$0.03$76.2M$68.4M = Details
5/7/21 Q221 $0.56$0.48 +$0.08$85.3M$84.5M = Details